93/11 (Pantoprazole sodium delayed-release 20 mg)

Pill with imprint 93/11 is Yellow, Elliptical / Oval and has been identified as Pantoprazole sodium delayed-release 20 mg. It is supplied by Teva Pharmaceuticals USA.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; duodenal ulcer; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93/11

Pantoprazole sodium delayed-release

Imprint:

93/11

Strength:

20 mg

Color:

Yellow

Size:

8.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Proton pump inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

calcium carbonate
calcium stearate
D&C Yellow No. 10
aluminum oxide
FD&C Yellow No. 6
hypromellose 2910 (15 mPa.s)
ferrosoferric oxide
ferric oxide yellow
lactose monohydrate
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol 4000
propylene glycol
shellac
sodium carbonate
stearic acid
magnesium silicate
titanium dioxide
triethyl citrate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
42291-0658	AvKare, Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.